Table 5.
Comparison of intragroup clinical characteristics, recessive model.
| CC + CG | GG | P | ||
| Controls (mean rank) | BMI (kg/m2) | 30.7 | 32.1 | p > 0.05 |
| AST (U/L) | 28.5 | 40.2 | p < 0.05 | |
| ALT (U/L) | 28.3 | 40.1 | p < 0.05 | |
| IR (HOMA) | 25.5 | 51.3 | p < 0.001 | |
| NASH (mean rank) | BMI (kg/m2) | 102 | 97.5 | p > 0.05 |
| AST (U/L) | 98.4 | 98.6 | p > 0.05 | |
| ALT (U/L) | 95.8 | 102 | p > 0.05 | |
| IR (HOMA) | 104 | 94.2 | p > 0.05 | |
| TG (mg/dL) | 94.6 | 91.9 | p > 0.05 | |
| GGT (U/L) | 80.8 | 77.7 | p > 0.05 | |
| TC (mg/dL) | 94.4 | 92.2 | p > 0.05 | |
| LDL (mg/dL) | 93.3 | 93.8 | p > 0.05 | |
| ALP (U/L) | 83.0 | 80.7 | p > 0.05 | |
| Total bilirubin (mg/dL) | 78.5 | 80.8 | p > 0.05 | |
| HDL (mg/dL) | 100 | 84.1 | p > 0.05 | |
| NAFLD (mean rank) | BMI (kg/m2) | 56.6 | 56.3 | p > 0.05 |
| AST (U/L) | 59.3 | 49.8 | p > 0.05 | |
| ALT (U/L) | 55.5 | 55.4 | p > 0.05 | |
| IR (HOMA) | 62.4 | 47.4 | p > 0.05 | |
| TG (mg/dL) | 52.3 | 53.9 | p > 0.05 | |
| GGT (U/L) | 44.9 | 42.6 | p > 0.05 | |
| TC (mg/dL) | 51.1 | 55.7 | p > 0.05 | |
| LDL (mg/dL) | 51.2 | 55.5 | p > 0.05 | |
| ALP (U/L) | 47.3 | 43.0 | p > 0.05 | |
| Total bilirubin (mg/dL) | 42.4 | 49.6 | p > 0.05 | |
| HDL (mg/dL) | 56.0 | 48.6 | p > 0.05 |
ALP = alkaline phosphatase, ALT = alanine aminotransferase, AST = aspartate aminotransferase (AST), BMI = body mass index, GGT = gamma-glutamyl transferase, HDL = high-density lipoprotein, IR (HOMA) = homeostasis model assessment of insulin resistance, LDL = low-density lipoprotein, NASH = non-alcoholic steatohepatitis, TC = total cholesterol, TG = triglyceride.